CompletedNCT00581009
Sleep deprivation and sertraline treatment for depression
About this title
Read the official source — NCT00581009Medication studyAges 18–75United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- Irvine and 1 more locationSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: May 30, 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 49
- Sponsor
- University of California, Irvine
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other, Radiation
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT00581009
- Official title
Show the full official title
The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Irvine · La Jolla
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, Irvine, a university.
Did this study involve medication?
Yes. The study involved medication, including sertraline, lithium.
Who was this study for?
Listed age limits: 18 years to 75 years.
